Literature DB >> 21607373

Ap-1 recognizes sequence elements on hiv-1 LTR in human epithelial tumor-cell lines.

V Zoumpourlis1, M Ergazaki, D Spandidos.   

Abstract

Investigation of the nucleotide sequence of the HIV-1 LTR showed the presence of four novel short DNA regions which are homologous to the recognition site for the cellular transcription factor AP-1. Four short oligonucleotide hybrids containing these potential AP-1 sites were constructed and used in gel retardation assays and in competition experiments in order to determine the role of the AP-L protein in the regulation of HIV-1 expression. The breast MDA MB 468 and cervical HeLa turner cell lines, which are known to overexpress the AP-1 protein were used in a gel retardation assay as a control to study the affinity of the AP-1 to synthesized oligonucleotide sequences. We have observed specific binding of nuclear factor AP-1 to three of these oligonucleotide hybrids. These results demonstrate the presence of three novel AP-1 binding sites on HIV-1 LTR, one of which was found within the TAR element and in the Tat protein binding region. Moreover, they suggest that AP-1 could be contributing to HIV-1 transcriptional regulation through its interaction with the AP-1 binding sites of HIV-1 LTR.

Entities:  

Year:  1994        PMID: 21607373     DOI: 10.3892/or.1.2.397

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

1.  Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.

Authors:  Christelle Mbondji-Wonje; Ming Dong; Xue Wang; Jiangqin Zhao; Viswanath Ragupathy; Ana M Sanchez; Thomas N Denny; Indira Hewlett
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

2.  Heat Shock Factor 1 Mediates Latent HIV Reactivation.

Authors:  Xiao-Yan Pan; Wei Zhao; Xiao-Yun Zeng; Jian Lin; Min-Min Li; Xin-Tian Shen; Shu-Wen Liu
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.